RECENT COMMENTS

  • David Ryner (don't play with numbers): I agree with Duncan and thank you Kathy. I number myself amongst many who suffer from a cr [...]   »Read more
  • Duncan Jefferson (don't play with numbers): A very common sense article and one that should be taken on board by all in the Health "In [...]   »Read more
  • Ken Campbell (recording consultations): I am clinical information offider for a UK cancer charity. I often recommend to patients t [...]   »Read more
  • Frank (recording consultations): Yes I had a pt request a consultation with me - I am concerned about the medicolegal aspec [...]   »Read more
  • Nicola Nicolai, Lara Bellardita, Massimo Maffezzini, Tiziana Magnani, Riccardo Valdagni and the Prostate Cancer Program Multidisciplinary Team at Fondazione IRCCS Istituto Nazionale dei Tumori, Milan: The topic is of great interest, with good points in favour as well as against the referral [...]   »Read more
  • Marian marie: It was next to impossible to manage my Thyroid Cancer after I had a Thyroidectomy in 1976. [...]   »Read more
  • Paul CORNES (centralising cancer services): Thank you both - I enjoyed reading this. The best systematic review on the topic comes [...]   »Read more
  • Steven Vermeulen: I was diagnose with adenocarcinoma with unknown primary in Oct. 2009. I was 54 years old, [...]   »Read more
  • Wolfgang Grisold (cancer treatment: agesim): Thank you for raising this interesting issue. Personally , I have the impression that at l [...]   »Read more
  • Gloria Freilich (cancer treatment: ageism): In my experience, having worked in the field of breast cancer from l987 to 2008 in a Londo [...]   »Read more

Receive our weekly e-newsletter

If you would like to receive the weekly CancerWorld newsletter which will contain the Article of the Week, please complete the information below

Full name:
Email:
Privacy:
 Accept Terms & Conditions 
 

 
 

e-ESO.net

E-eso

Online educational resources Including e-grandrounds, weekly online meetings in collaboration with Nature Reviews Clinical Oncology - CME accredited!

Next live sessions:

GR245 - Multidisciplinary treatment of malignant thymoma

GR246 - New CNS Profilaxis and treatment in Nodal NHL. Evidence based recommendations

GR32 - Imaging in oncology – over a century of advances

The website is supported by an unrestricted educational grant provided by:

Founding sponsor

CancerWorld invites you to visit:

E-eso
European School of Oncology -
ESO Established in 1982, a non-profit organisation exclusively dedicated to increasing the knowledge of health professionals in cancer care.
E-aso
Euro-Arab School of Oncology - is a joint initiative between the Egyptian Ministry of Health and Population and ESO. EASO intends to enhance and support education in the oncology field in all the Arab countries.
 
CancerWorld is a pioneering initiative of the European School of Oncology financially supported through Sharing Progress in Cancer Care, a collaborative programme between ESO and Amgen, Boehringer Ingelheim, Celgene, Eisai, Eli Lilly, Genomic Health, GlaxoSmithKline, Helsinn, Merck Serono, Novartis, Roche and Sanofi Aventis.